Replimune Group Inc sell BMO Capital Markets
Start price
13.04.26
/
50%
€1.51
Target price
13.04.27
€0.86
Performance (%)
381.01%
Price
09:33
?
Summary
This prediction is currently active. The price for Replimune Group Inc has massively increased, which is bad news for the SELL prediction by BMO_Capital_Markets. This prediction currently runs until 13.04.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Replimune Group Inc | -7.993% | -7.993% |
| iShares Core DAX® | -2,80 % | -1,40 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % |
| iShares S&P 500 | -3,41 % | 0,40 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Replimune Group Inc diskutieren
Replimune Group (REPL) was downgraded by BMO Capital Markets from "market perform" to "underperform". They now have a $1.00 price target on the stock.
Ratings data for REPL provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Replimune Group Inc
Replimune Group Inc
Start price
Target price
Perf. (%)
€12.90
22.01.25
22.01.25
€25.92
22.01.26
22.01.26
-48.84%
23.01.26
23.01.26
Replimune Group Inc
Start price
Target price
Perf. (%)
€15.40
22.11.24
22.11.24
€17.31
22.11.25
22.11.25
-49.03%
23.11.25
23.11.25

